PCI Biotech Holding ASA (OSTO:PCIBO)
kr 1.8 0 (0%) Market Cap: 48.60 Mil Enterprise Value: 18.54 Mil PE Ratio: 0 PB Ratio: 1.52 GF Score: 29/100

Q1 2021 PCI Biotech Holding ASA Earnings Call Transcript

May 07, 2021 / 06:30AM GMT
Release Date Price: kr31.9
Ronny Skuggedal
PCI Biotech Holding ASA - CFO

Yes, good morning and welcome to PCI Biotech's Q1 Presentation held here at Oslo Cancer Cluster Innovation Park. My name is Ronny Skuggedal, and I'm the CFO of the company. Unfortunately, I need to inform you that our CEO, Per Walday, is acute ill, so I need to take this presentation on short notice. That's, of course, unfortunate, but I will do my best.

So before we start with the presentation, please notice our important notice and disclaimer. At the end of the presentation, we will have a Q&A session, open both through our telephone conference facility, where you can dial-in for questions; but you can also, as usual, post questions through the webcast console. We will start the Q&A sessions with the telephone conference facility. And you can find the details both in the slides and in the invite for the presentation.

So first, a couple of words, intro words about PCI Biotech. We have an enabling technology, enabling intracellular delivery. We use this platform technology for 3 different programs: fimaCHEM, our lead program, now in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot